Patient-Derived Organoids as a Platform to Decipher and Overcome Radioresistance: From the Tumor Microenvironment to Radiosensitizer Discovery

Patient-derived organoids (PDOs) preserve patient genotypes and 3D architecture, offering a useful platform to investigate mechanisms of radioresistance and test radiosensitizers. We outline an end-to-end workflow—model establishment, multi-omics profiling, pharmacologic screening, and in vivo confi...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Dashan Yin, Xiujuan Hong, Xiaoqi Wang, Wenjia Ding, Chenli Wang, Jin Qian, Yi Zhou, Chuan Sun, Zhibing Wu
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2025-12-01
Cyfres:	Current Oncology
Pynciau:	patient-derived organoids (PDOs) radioresistance radiosensitizers radiotherapy (RT) tumor microenvironment (TME) cancer stem cells (CSCs)
Mynediad Ar-lein:	https://www.mdpi.com/1718-7729/32/12/680
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!